Presenteeism: How Flawed Medical Systems Incentivize Risk to Patients
During the COVID-19 pandemic, clinicians should be extremely mindful of assessing their own symptoms before making the decision about whether to treat patients or stay home.
Policy
Lifting COVID-19 “Lockdown” Restrictions May Cause Infection Resurgence
Lifting “lockdown” restrictions imposed to reduce the spread of COVID-19 would most likely result in a resurgence of infections.
ACP: US Response to COVID-19 Identifies Inequalities in Health Care System
The American College of Physicians statement outlines how the “status quo” created health inequalities and prevented the spread of the COVID-19 virus, and outlines steps on how to move forward.
FDA: Guidance on Digital Therapeutics for Psychiatric Disorders During COVID-19
The FDA has issued new guidance regarding the use of computerized behavioral therapy and other digital health therapeutic devices for psychiatric disorders during the coronavirus disease 2019 (COVID-19) pandemic.
Drug Shortages Reported as New Program Created to Expedite Treatments for COVID-19
To expedite development, the FDA has created a special emergency program called the Coronavirus Treatment Acceleration Program.
Compliance With FDA Reporting Guidelines for Clinical Trials Is Low, Not Improving
Cohort study data from 2018 to 2019 suggest poor compliance with the US Food and Drug Administration reporting requirements for clinical trial sponsors.
Say Goodbye to High-Stakes Recertification? NCCPA Pilots Alternative Recertification Testing
Many providers who are required to take recertification examinations feel as though standard CMS is just as effective in skill maintenance as studying and sitting for a 200-question examination.
Who Wins in Salary-Only Physician Compensation Plans?
A new study demonstrates the efficacy of a structured physician compensation model in achieving equitable pay for all employees, although the underrepresentation of women in leadership positions and the higher-paying specialties warrants further investigation.
ACP Recommendations for Rising Prescription Drug Costs
The United States routinely outspends other high-income countries on prescription drugs because of the lack of price controls or negotiation by government health care systems.
Are Application Costs Reducing Diversity in the Medical Field?
Medical school application costs may prevent students from lower-income backgrounds from entering the profession of medicine.
-
Loading...
-
Loading...
Next post in Practice Management Information Center
